Published in Pharma Investments, Ventures and Law Weekly, November 20th, 2005
Total revenues in the third quarter of 2005 were $7.4 million, compared to $4.4 million in the third quarter of 2004. Total revenues in the 9 months ended September 30, 2005, were $17.4 million, compared to $11.6 million in the 9 months ended September 30, 2004.
Arena reported a net loss allocable to common stockholders in the third quarter and the 9 months ended September 30, 2005 of $16.1 million, or $0.46 per share, and $57.5 million, or $1.69 per share, respectively. This compares with a net loss allocable to common...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.